ARCHIVES

Patient Advocacy: FDA, NCI Developing Methods For Naming Survivors To Boards

This article is from The Cancer Letter archive.

Vol. 23 No. 05 | February 7, 1997

Download PDF Visit The Full Archive

Related Articles

In Brief: Greenwald Reorganizing DCPC, Elevates Surveillance to Program, Moves Branches

February 3, 1989

NCI Cancer Studies In China Intact; Visits Delayed

July 14, 1989

Amgen Agrees To Buy Immunex For $16 Billion In Stock And Cash.

January 25, 2002

ICCCR Issues RFP For Cancer Risk Scale

March 6, 1992

ACS Asks $1.5 Billion for NCI; Waxman Considers Requiring NIH To Send Budget Directly To Congress

March 4, 1983

ASCO Urges NCI To Spell Out Metrics of Success Beyond Cutting Groups to Arbitrary Number

June 17, 2011